Fas ligand as a tool for immunosuppression and generation of immune tolerance (Q35944753)

11 August 2017

1 reference

title

Fas ligand as a tool for immunosuppression and generation of immune tolerance (English)

1 reference

11 August 2017

1 reference

Osnat Bohana-Kashtan

1

1 reference

PubMed ID

15536183

11 August 2017

Curt I Civin

series ordinal

2

1 reference

11 August 2017

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

22

1 reference

11 August 2017

6

1 reference

11 August 2017

908-924

1 reference

Increased serum soluble Fas ligand associated with recurrent B-cell non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.

11 August 2017

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Intrathecal Fas ligand infusion strengthens immunoprivilege of central nervous system and suppresses experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Specific immunotherapy by genetically engineered APCs: the "guided missile" strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1634%2FSTEMCELLS.22-6-908

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/364806A0

Cell Death in Development

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(00)80564-4

Identifiers

DOI

10.1634/STEMCELLS.22-6-908

1 reference

11 August 2017

1 reference

PubMed ID

15536183